Search Count: 16
 |
Discovery Of An Orally Bioavailable Reversible Covalent Sars-Cov-2 Mpro Inhibitor With Pan-Coronavirus Activity
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.37 Å Release Date: 2025-08-20 Classification: HYDROLASE/INHIBOTOR Ligands: A1L7M |
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2025-08-20
Ligands: A1L7M
 |
Discovery Of An Orally Bioavailable Reversible Covalent Sars-Cov-2 Mpro Inhibitor With Pan-Coronavirus Activity
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.89 Å Release Date: 2025-08-20 Classification: HYDROLASE/INHIBITOR |
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2025-08-20
 |
Discovery Of An Orally Bioavailable Reversible Covalent Sars-Cov-2 Mpro Inhibitor With Pan-Coronavirus Activity
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.50 Å Release Date: 2025-08-20 Classification: HYDROLASE/INHIBITOR |
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2025-08-20
 |
Discovery Of An Orally Bioavailable Reversible Covalent Sars-Cov-2 Mpro Inhibitor With Pan-Coronavirus Activity
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.47 Å Release Date: 2025-08-20 Classification: HYDROLASE/INHIBITOR Ligands: A1L7M |
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2025-08-20
Ligands: A1L7M
 |
Discovery Of An Orally Bioavailable Reversible Covalent Sars-Cov-2 Mpro Inhibitor With Pan-Coronavirus Activity
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2025-08-20 Classification: HYDROLASE/INHIBITOR Ligands: A1L7M |
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2025-08-20
Ligands: A1L7M
 |
Structure-Activity Relationship Studies Of Allosteric Inhibitors Of Eya2 Tyrosine Phosphatase
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.49 Å Release Date: 2021-12-29 Classification: TRANSCRIPTION Ligands: 1RI |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-12-29
Ligands: 1RI
 |
Structure-Activity Relationship Studies Of Allosteric Inhibitors Of Eya2 Tyrosine Phosphatase
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.30 Å Release Date: 2021-12-29 Classification: TRANSCRIPTION Ligands: 1SI |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-12-29
Ligands: 1SI
 |
Fragment-Based Lead Discovery Of Indazole-Based Compounds As Axl Kinase Inhibitors
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.15 Å Release Date: 2021-10-13 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: E56 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-10-13
Ligands: E56
 |
Strategic Design Of Catalytic Lysine-Targeting Reversible Covalent Bcr-Abl Inhibitors
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.72 Å Release Date: 2021-06-09 Classification: TRANSFERASE Ligands: FVC |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-06-09
Ligands: FVC
 |
Strategic Design Of Catalytic Lysine-Targeting Reversible Covalent Bcr-Abl Inhibitors
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2021-06-09 Classification: TRANSFERASE Ligands: HJ9 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-06-09
Ligands: HJ9
 |
Crystal Structure Of Wild Type Mnk2 In Complex With Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.90 Å Release Date: 2020-02-12 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: BV9 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2020-02-12
Ligands: BV9
 |
Crystal Structure Of Smyd3 In Complex With Covalent Inhibitor 5
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.35 Å Release Date: 2019-08-14 Classification: TRANSFERASE/INHIBITOR Ligands: A8U, ZN, SAM |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2019-08-14
Ligands: A8U, ZN, SAM
 |
Structural Basis For An Allosteric Eya2 Phosphatase Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.18 Å Release Date: 2019-06-05 Classification: TRANSCRIPTION Ligands: 9FX |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2019-06-05
Ligands: 9FX
 |
Crystal Structure Of Smyd3 In Complex With Covalent Inhibitor 4
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.14 Å Release Date: 2018-10-17 Classification: TRANSFERASE/INHIBITOR Ligands: ZN, 8W0, SAM |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-10-17
Ligands: ZN, 8W0, SAM
 |
Crystal Structure Of Rbbp4-Peptide Complex
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.69 Å Release Date: 2018-07-11 Classification: TRANSCRIPTION |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-07-11
 |
The Crystal Structure Of 14-3-3-Sigma At 2.8 Angstrom Resolution
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.80 Å Release Date: 2005-03-08 Classification: SIGNALING PROTEIN |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2005-03-08